TrialEuropean journal of clinical pharmacology2013

CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.

Sze Wa Chan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.